111 related articles for article (PubMed ID: 26040047)
1. Interferon-gamma-release assay prevents unnecessary tuberculosis therapy.
Schichter-Konfino V; Halasz K; Grushko G; Snir A; Haj T; Vadasz Z; Kessel A; Potasman I; Toubi E
Isr Med Assoc J; 2015 Apr; 17(4):223-6. PubMed ID: 26040047
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany.
Diel R; Nienhaus A; Loddenkemper R
Chest; 2007 May; 131(5):1424-34. PubMed ID: 17494792
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the impact of interferon-gamma release assays on the management of childhood tuberculosis.
Ling DI; Crépeau CA; Dufresne M; Khan S; Quach C; Dendukuri N; Schwartzman K; Menzies D; Lands LC; Pai M
Pediatr Infect Dis J; 2012 Dec; 31(12):1258-62. PubMed ID: 22828646
[TBL] [Abstract][Full Text] [Related]
4. QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.
Rutherford ME; Nataprawira M; Yulita I; Apriani L; Maharani W; van Crevel R; Hill PC; Alisjahbana B
Int J Tuberc Lung Dis; 2012 Apr; 16(4):496-502. PubMed ID: 22325792
[TBL] [Abstract][Full Text] [Related]
5. Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update.
Diel R; Loddenkemper R; Niemann S; Meywald-Walter K; Nienhaus A
Am J Respir Crit Care Med; 2011 Jan; 183(1):88-95. PubMed ID: 20802162
[TBL] [Abstract][Full Text] [Related]
6. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).
Gudjónsdóttir MJ; Kötz K; Nielsen RS; Wilmar P; Olausson S; Wallmyr D; Trollfors B
BMC Infect Dis; 2016 Oct; 16(1):540. PubMed ID: 27716176
[TBL] [Abstract][Full Text] [Related]
7. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays.
Mazurek GH; Zajdowicz MJ; Hankinson AL; Costigan DJ; Toney SR; Rothel JS; Daniels LJ; Pascual FB; Shang N; Keep LW; LoBue PA
Clin Infect Dis; 2007 Oct; 45(7):826-36. PubMed ID: 17806046
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis.
Diel R; Loddenkemper R; Meywald-Walter K; Niemann S; Nienhaus A
Am J Respir Crit Care Med; 2008 May; 177(10):1164-70. PubMed ID: 18276940
[TBL] [Abstract][Full Text] [Related]
9. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
10. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
12. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
13. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
[TBL] [Abstract][Full Text] [Related]
14. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
[TBL] [Abstract][Full Text] [Related]
15. Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school.
Higuchi K; Harada N; Mori T; Sekiya Y
Respirology; 2007 Jan; 12(1):88-92. PubMed ID: 17207031
[TBL] [Abstract][Full Text] [Related]
16. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland.
Kruczak K; Duplaga M; Sanak M; Cmiel A; Mastalerz L; Sladek K; Nizankowska-Mogilnicka E
Scand J Infect Dis; 2014 Sep; 46(9):649-55. PubMed ID: 25073535
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
18. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients.
Lee YM; Lee SO; Choi SH; Kim YS; Woo JH; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
J Infect; 2014 Aug; 69(2):165-73. PubMed ID: 24647146
[TBL] [Abstract][Full Text] [Related]
19. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities.
Grinsdale JA; Ho CS; Banouvong H; Kawamura LM
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1614-20. PubMed ID: 22118167
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants.
Orlando G; Merli S; Cordier L; Mazza F; Casazza G; Villa AM; Codecasa L; Negri E; Cargnel A; Ferrarese M; Rizzardini G
Infection; 2010 Jun; 38(3):195-204. PubMed ID: 20411295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
